NCT05208905View on ClinicalTrials.gov

LIFE-BTK PK Sub-study

NAActive, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

April 18, 2023

Study Completion Date

February 22, 2028

Conditions
Critical Limb Ischemia (CLI)
Interventions
DEVICE

Esprit BTK Device

Participants will receive Esprit BTK Device

Trial Locations (5)

32256

First Coast Cardiovascular Institute, Jacksonville

74006

Ascension St. John Jane Phillips, Bartlesville

02747

Charlton Memorial Hospital, South Dartmouth

Unknown

Sir Charles Gairdner Hospital, Nedlands

National Taiwan University Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT05208905 - LIFE-BTK PK Sub-study | Biotech Hunter | Biotech Hunter